Nektar Therapeutics | NKTR - Passività Correnti





Passività Correnti Cambiamento Data
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 23.23B 2.27B 2026-09
Baxter International USD 3.81B 218M 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
Biogen USD 3.9B 18.7M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Cara Therapeutics USD 11.26M 216K 2026-03
Cipla INR 69.77B 366.6M 2026-09
Dr.Reddys Laboratories INR 154.3B 3.04B 2026-09
Eisai JPY 393.64B 53.39B 2026-06
Eli Lilly USD 47B 745M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
Ironwood Pharmaceuticals USD 34.73M 1.88M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Merck USD 28.8B 1.07B 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Pfizer USD 31.73B 920M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Takeda JPY 2.6T 161B 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
Xencor USD 76.27M 5.6M 2026-09